Summary
A collimated whole-body counter was used to measure the retention and distribution of radioactivity along the longitudinal axis of the body at several times during the 24 hours after the intravenous injection of 50 μCi of Tc-99m-diphosphonates. Whole-body retention (WBR) was measured together with regional uptakes in the following four areas: head, chest, bladder, and legs using two structurally related Tc-99m-diphosphonate skeletal imaging agents: 1-hydroxyethylidene diphosphonate (HEDP) and methylene diphosphonate (MDP). The average 24 hour WBR values in young males, reflecting skeletal uptake of these tracers, were 17.7±2.2% (n=20) and 31.0±2.4% (n=3), respectively. A model of skeletal clearance was developed using the sum of two exponentials. In normal volunteers the initial rapid clearance phase of both tracers had a half-time of about 1 hour, whereas the slower second phase clearance had a half-time of 22 hours with HEDP and 44 hours with MDP. The WBR is usually calculated for the entire body only at 24 hours, but with the improved spatial resolution of a collimated whole-body counter, regional measurements could potentially be done over shorter periods (6–8 hours) in order to simplify the procedure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ell PJ, Jarritt PH, Cullum I, Lui D (1984) The MDP skull uptake test: a new diagnostic tool. JNM 25:24
Meindok H, Rapopart A, Oreopoulos DG, Rabinovich S, Meema HE, Meema S (1985) Quantitative radionuclide scanning in metabolic bone disease. Nuc Med Comm 6:141–148
Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR (1978) The use of whole-body retention of Tc-99m-diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19:270–275
Martin W, Fogelman I, Bessent R (1981) Measurement of 24 hour whole body retention of Tc-99m HEDP by a gamma camera. JNM 22:542–545
Castronovo F Jr, McKusick KA, Dann J, Prout GR Jr, Strauss WH (1985) A simplified technique for quantifying 24-hour whole body retention of Tc-99m-labeled methylene diphosphonate (MDP). Int J Nucl Med Biol 12:209–214
Fogelman I, Bessent RG, Beastall G, Boyle IT (1980) Estimation of skeletal involvement in primary hyperparathyroidism. Ann Int Med 92:65–67
Hylstrup L, Mogensen N, Jensen GF, McNair P, Transbol I (1984) Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism. Scand J Clin Lab Invest 44:105–109
Steven MM, Sturrock RD, Fogelman I, Smith L (1982) Whole body retention of diphosphonate in rheumatoid arthritis. J Rheum 9:873–877
Thomsen K, Gotfredsen A, Christiansen C (1986) Bone turnover in healthy adults measured by whole body retention and urinary excretion of 99m-Tc-MDP. Normalization by bone mass. Scand J Clin Lab Invest 46:587–592
Thomsen K, Johansen J, Nilas L, Christiansen C (1987) Whole body retention of 99m-Tc-diphosphonate. Relation to biochemical indices of bone turnover and to total body calcium. Eur J Nuc Med 13:32–35
Thomsen K, Nilas L, Mogensen T, Christiansen C (1986) Determination of bone turnover by urinary excretion of 99m-Tc-MDP. Eur J Nuc Med 12:342–345
Davie MWJ, Britton JM, Haddaway M, McCall IW (1987) 99m-Tc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy. Eur J Nucl Med 13:462–466
Fogelman I, Martin W (1983) Assessment of skeletal uptake of Tc-99m diphosphonate over a five-day period. Eur J Nucl Med 8:489–490
Bergmann P, Paternot T, Schoutens A (1983) Regional measurement of bone calcium accretion rate and exchangeable pool with a whole-body counter: method and studies in subjects without bone disease. Calcif Tissue Int 35:21–28
Martin P, Schoutens A, Manicourt O, Bergman, P, Fuss M, Verbanck M (1983) Whole body and regional retention of Tc-99m-labeled pyrophosphonate at 24 hours: physiological basis of the method for assessing the metabolism of bone in disease. Calcif Tissue Int 35:37–42
Arnold JS, Barnes WE, Khedker N, Nelson M. Computerized kinetic analysis of two Tc-99m-Sn-diphosphonates demonstrating different binding characteristics. In: Mazess RB (ed) 4th Int Conf on Bone Measurement. U.S. department HEW, NIH publication 80-1938, Washington DC, pp 454–466
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molloi, S., Mazess, R., Bendsen, H. et al. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: A study with normal males. Calcif Tissue Int 44, 322–329 (1989). https://doi.org/10.1007/BF02556311
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02556311